Key Moments
Peptides: The Science, Uses & Safety | Dr. Abud Bakri
Andrew HubermanWant to know something specific about what's covered?
We've already dissected every moment. Ask and we will deliver (with timestamps).
Key Moments
Peptides like BPC-157 have shown astonishing regenerative effects across diverse animal tissues, yet their human safety and efficacy remain largely unstudied, leading to a dangerous 'Wild West' market with unknown risks for millions of users.
Key Insights
Peptides can be broadly categorized into two types: those with known receptors (like GLP-1 agonists, e.g., Ozempic) and those with no clearly identified receptors, such as BPC-157 and TB-500, which complicates understanding their mechanisms.
BPC-157, a 15-amino acid fragment of a larger gastric protein discovered in Croatia in the 1990s, has extensive animal data showing accelerated healing of tendons, ligaments, and nerves, even in conditions like severed Achilles tendons and ACLs, as well as neuroprotective effects in alcohol withdrawal, but only one small human trial for ulcerative colitis exists, with data not fully public.
Despite promising animal data showing BPC-157's robust regenerative and anti-stress properties (e.g., increasing growth hormone receptors on tendons and enhancing VEGF signaling for blood vessel formation), there is no clear human safety data regarding its potential to accelerate tumor growth, though animal studies have not indicated a carcinogenic signal.
Russian peptides like Pinealon (EDR) and Epitalon, discovered by Dr. Vladimir Khavinson, are epigenetic modifiers that bind to DNA to influence gene expression, with Pinealon reportedly improving brain metabolism and athletic performance, and Epitalon (a pineal gland derivative) potentially increasing melatonin synthesis and improving immune function by influencing clock genes and extending lifespan in a 15-year human study.
The thymus gland, essential for T-cell development, undergoes significant involution (shrinkage) after puberty driven by hormones like androgens and estrogens; studies show that growth hormone, Metformin, and DHEA cocktails can regenerate thymic tissue and improve immune markers in humans, linking thymic health directly to longevity and immune competence.
GLP-1 agonists (e.g., semaglutide, tirzepatide) are revolutionizing metabolic health, causing 10-30% body weight loss and reversing chronic diseases, but the long-term effects on brain function, motivation (anhedonia), and the necessity of lifelong administration are not fully understood, especially with their thousandfold increase in GLP concentration compared to natural levels.
A new framework for understanding peptides: Receptor-based versus receptor-elusive
The world of peptides is vast and often confusing, with Dr. Abud Bakri introducing a foundational distinction: peptides with known, specific receptors (like GLP-1 agonists such as Ozempic and Monjaro) versus those whose primary mechanisms of action remain elusive, lacking identified receptors (such as BPC-157 and TB-500). This distinction is critical because receptor-based peptides tend to have more predictable and potent clinical effects, while those without clear receptors, despite often showing impressive biological activity in animal models, pose greater challenges for mechanistic understanding and regulatory approval. This ambiguity contributes to the 'Wild West' nature of the non-pharmaceutical peptide market, where efficacy and safety data are often anecdotal or limited to a single research group, primarily in animals. Understanding this classification is key for evaluating the scientific rigor and potential risks associated with various peptides, as the absence of a known receptor does not mean a peptide is inactive, but rather, that its precise biological 'language' for cellular communication is yet to be fully deciphered.
BPC-157: A gut-derived peptide with astonishing animal regenerative properties
BPC-157, a synthetic 15-amino acid fragment derived from a larger protein found in gastric juice, has garnered immense interest due to its remarkable regenerative capabilities observed extensively in animal studies. Originating from Croatian research in the 1990s, this peptide has been shown to accelerate healing across a diverse range of tissues, including severed tendons (like the Achilles), ligaments (such as the ACL), and even neural pathways. Animals treated with BPC-157 demonstrate faster recovery from burn wounds, reduced gastric ulcers during stress (even with corticosteroid administration), and intriguing neuroprotective effects, such as reduced alcohol intoxication and withdrawal symptoms. Mechanistically, BPC-157 appears to modulate key growth and healing pathways, including increasing vascular endothelial growth factor (VEGF) for angiogenesis, enhancing cell migration, and upregulating growth hormone receptors in damaged tissues. Despite this compelling preclinical evidence, human studies are almost non-existent beyond a small, unpublished Phase 1/2 trial for ulcerative colitis using rectal enemas. The original intent was for gastrointestinal repair, not musculoskeletal injury, highlighting a significant disconnect between its initial discovery context and its current popular application.
The legal and market complexities of BPC-157: A regulatory minefield
The legal status and commercial landscape of BPC-157 are incredibly convoluted, creating a significant challenge for both clinicians and consumers. Historically available from "research purposes only" gray market websites, BPC-157 was recently moved to a Category 2 list by the FDA, effectively banning compounding pharmacies from producing it, though some continue to offer it under slight chemical modifications (e.g., PDA: Pentadecapeptide Arginate). This regulatory environment means that while BPC-157 remains widely accessible online, its purity, dosage, and freedom from contaminants are largely unregulated, posing substantial health risks. State medical boards vary in their stance, further complicating physician prescribing. The ethical dilemma for clinicians is profound: they operate in a landscape where anecdotally powerful benefits are reported, but formal human safety and efficacy data are almost entirely absent, making prescription a high-risk proposition for licensure and malpractice. Dr. Bakri emphasizes the urgent need for formal clinical trials to clarify BPC-157's role, as the current situation risks either withholding a potentially revolutionary therapeutic or exposing millions to untested and potentially harmful substances.
Russian bio-regulator peptides: Epigenetic modulators for longevity and cognitive function
Moving beyond BPC-157, the discussion delves into Russian bio-regulator peptides, notably Pinealon (EDR) and Epitalon, developed by Dr. Vladimir Khavinson. These peptides are distinct in that they are believed to act as epigenetic modifiers, binding to DNA grooves to facilitate gene expression, rather than interacting with specific cell surface receptors. Pinealon, a tripeptide derived from brain cortex extract (despite its name), is described as a 'brain regulator' that enhances brain metabolism and cognitive performance. Anecdotal reports, including personal experiences, suggest Pinealon can drastically increase REM sleep and improve daytime alertness, challenging conventional wisdom about sleep cycle modulation. Conversely, Epitalon, originating from the pineal gland, is known for its role in timing melatonin production and enhancing immune function through clock gene expression. Khavinson's seminal 15-year longevity study, albeit a Russian study, reportedly showed significant reductions in cardiovascular disease, cancer, and infectious risk in nursing home patients receiving Epitalon and a thymus peptide, suggesting profound anti-aging effects by restoring youthful genetic programs and physiological rhythms.
Thymus and immunity: The overlooked gland and its peptide activators
The thymus, a crucial yet often overlooked immune organ, plays a central role in T-cell development and immune competence. Present at birth, it grows until puberty, then dramatically involutes (shrinks) under the influence of sex hormones and stress, becoming largely fatty residue by adulthood. This thymic involution is directly linked to increased susceptibility to infections, autoimmune diseases, and cancers. Intriguingly, growth hormone has been shown to regenerate thymic tissue, even in adults, and clinical studies combining growth hormone, Metformin, and DHEA have demonstrated increased thymic size and improved T-cell profiles. Thymus-derived peptides like Thymosin Alpha 1 (TA1) and Thymosin Beta 4 (TB4) are key players. TA1, once FDA-approved for immune-compromised children, is an 'immune jet fuel' that enhances T-cell development and pathogen attack. TB4, a 43-amino acid peptide, aids in cellular actin cytoskeleton reorganization, facilitating immune cell movement and tissue repair (popularly used in animal doping, particularly horses, for its healing properties). The lack of modern 'thymologists' in mainstream medicine leaves a significant gap in promoting general immune health, despite the potent effects of these peptides and simple metrics like the lymphocyte-to-monocyte ratio in standard blood tests as a powerful indicator of immune status.
GHK-Cu: The 'glow stack' peptide and its multifaceted regenerative potential
GHK-Cu, a tripeptide (Glycine-Histidine-Lysine) complexed with copper, is renowned in aesthetic medicine as the 'collagen regulator.' Discovered by Dr. Loren Pickart in the 1970s, GHK-Cu is highly abundant in youthful serum and skin and significantly declines with age, paralleling the loss of skin elasticity and hair health. It actively participates in both the synthesis and breakdown of type I collagen, essential for tissue remodeling and repair, ensuring healthy collagen structures rather than pathogenic scarring. Topically, GHK-Cu has shown promising effects comparable to retinol and vitamin C in reducing wrinkles and improving skin appearance, particularly synergistically with red light therapy, and potentially mitigating UV damage. While its use in injectable form is not FDA-approved and lacks human data, topical formulations are gaining traction within both traditional skincare and the growing "looksmaxing" community. Beyond aesthetics, nascent research from Chinese groups is exploring GHK-Cu for lung regeneration, given the high connective tissue content in the lungs and potential for healing in conditions like COPD and post-COVID lung damage, hinting at broader systemic regenerative applications that extend beyond skin and hair.
GLP-1 agonists: Reshaping metabolic health with unprecedented weight loss
GLP-1 agonists, such as semaglutide (Ozempic, Wegovy) and tirzepatide (Zepbound, Monjaro), represent a paradigm shift in metabolic medicine, driven by their ability to induce 10-30% body weight loss, an unprecedented feat in pharmaceutical interventions. These agents, originally discovered in Gila monster saliva, were engineered for longer half-lives by pharmaceutical companies after early observations of weight loss in diabetic patients. Their mechanism involves a thousand-fold increase in GLP-1 signaling, dramatically suppressing appetite and improving insulin sensitivity. Dr. Bakri underscores their critical role in potentially averting a collapse of the healthcare system under the weight of surging obesity and pre-diabetes epidemics. While the immediate benefits for weight loss and reversal of chronic metabolic diseases are compelling, clinicians grapple with substantial long-term questions: potential for lifelong dependency, weight regain upon cessation, and the impact of sustained, supraphysiological GLP-1 levels on brain function, mood (reports of anhedonia), and neuroplasticity, particularly in younger populations. Careful titration, comprehensive lifestyle integration, and monitoring for nutrient deficiencies and electrolyte imbalances are essential to mitigate adverse effects and ensure healthy weight management, rather than simple dramatic weight reduction.
The 'trinity stack' and the future of peptide integration in health
The intersection of various peptide categories has led to emerging 'stacks' among health enthusiasts and celebrities aiming for rapid and dramatic body transformations. The "trinity stack," for instance, combines GLP-1 agonists for insulin sensitivity and fat loss, growth hormone secretagogues (like tesamorelin or MK-677) to increase muscle mass and recovery, and androgen modulation therapies (like TRT) for anabolic effects. This potent combination enables significant fat loss and muscle gain in short periods. While the allure of such rapid results is high, the health implications of these combinations, especially for those not under stringent medical supervision, remain largely unknown. The growth hormone secretagogues themselves, while promoting youthful skin and muscle, also raise concerns about insulin insensitivity and potential for accelerating pre-existing cancers, requiring a careful risk-benefit analysis. Dr. Bakri foresees a future where peptides are integrated into comprehensive health protocols, moving beyond isolated use. This would involve combining them with foundational lifestyle practices (morning sunlight, optimal sleep, unprocessed diet) and using them cyclically. However, this future hinges on robust clinical trials, clearer regulatory guidance, accessible and reliable sourcing, and a medical community willing to engage with and educate patients on these powerful, yet poorly understood, compounds.
Mentioned in This Episode
●Supplements
●Products
●Companies
●Organizations
●Drugs & Medications
●Concepts
●People Referenced
Common Questions
Peptides can be categorized by whether they have known, specific receptors (like GLP-1 agonists) or if their receptors are unknown and they impact biology in more indirect ways, often through epigenetic modification (like BPC-157 or Russian peptides).
Topics
Mentioned in this video
An FDA-approved GLP-1 agonist for diabetes and weight loss, often in short supply from traditional pharmaceutical versions.
An FDA-approved GLP-1/GIP receptor agonist for diabetes, also used off-label for weight loss, and subject to supply shortages.
A triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors, with significant potential for weight loss.
An FDA-approved GLP-1/GIP receptor agonist for weight loss.
Stimulant medications that some users report are blunted in their effects when combined with BPC-157, suggesting an interaction with dopaminergic signaling.
A peptide originally derived from gastric juices, studied for gut health, tissue repair, and neurological effects, but with limited human trials and uncertain legal status.
A growth hormone-releasing hormone (GHRH) analogue, an FDA-approved growth hormone secretagogue, that can increase growth hormone and IGF-1 levels.
A non-peptide growth hormone secretagogue that stimulates growth hormone secretion, and can increase hunger.
A tripeptide with a copper ion, found in type I collagen, studied for skin and hair health and potential tissue regeneration.
A four-amino acid peptide from the pineal gland, associated with DNA repair, longevity, and regulation of clock genes.
A tripeptide from brain extract, noted for effects on REM sleep, cognitive function, and athletic performance, acting as an epigenetic modifier.
A re-labeled version of BPC-157 used by compounding pharmacies to circumvent regulations after BPC-157 was moved to a restricted category.
A comprehensive nutritional supplement combining vitamins, minerals, prebiotics, probiotics, and adaptogens.
A combination supplement offered by AG1.
A thymic hormone that increases T-cell development and immune response, once FDA-approved for certain immune deficiencies, and used in other countries as adjunctive cancer therapy.
A 43-amino acid peptide that reorganizes the actin cytoskeleton in cells, enhancing cell migration; common doping agent in horse racing.
An essential trace mineral critical for thymulin production; zinc depletion can lead to decreased thymulin levels.
A synthetic melanocortin peptide that increases melanin production and can cause skin darkening. Mentioned as a potential contaminant in gray market peptides.
A sleep supplement designed to improve slow-wave deep sleep and REM sleep.
A nine-amino acid peptide that serves as a marker of thymus function, decreases with age, is zinc-dependent, and can augment effects of hormones.
An essential mineral, mentioned as a common supplement.
A well-known supplement for muscle growth and performance, also with potential cognitive benefits.
An internal medicine physician with encyclopedic knowledge of peptides, emphasizing their scientific basis, clinical application, and safety profiles.
Famous scientist known for conditioning experiments, also sold dog gastric juices as medicine for GI distress and wound healing.
Scientist who developed the stress adaptation theory, observing physiological changes in stressed animals like adrenal enlargement and gastric damage.
A public figure known for work in crypto, who openly discusses personal peptide use and claims gray market peptides are identical to compounding pharmacy versions based on his tests.
American researcher who discovered GHK-Cu copper in collagen tissue and studied its role in collagen synthesis and breakdown.
A renowned neuroanatomist from UCSD, whose opinions on pineal gland calcification were initially dismissed by Huberman.
Dr. Fahy conducted the TRIM (Thymus Regeneration, Immunorestoration, and Insulin Mitigation) trial, studying the regrowth of the thymus using a cocktail of growth hormone, Metformin, and DHEA.
A Soviet researcher who discovered various bioregulatory peptides from organ extracts, including Epitalon and Pinealon, with a focus on anti-aging and performance enhancement.
Provides over 160 advanced lab tests and analyzes results to offer health improvement recommendations.
Pharmaceutical company that manufactures Mounjaro and is involved in developing Retatrutide, navigating patent laws for peptides.
Pharmaceutical company that manufactures Ozempic and Wegovy, and is involved in the GLP-1 market.
More from Andrew Huberman
View all 385 summaries
36 minThe Science & Process of Healing from Grief | Huberman Lab Essentials
137 minBuild Muscle, Great Posture & Resilience to Injury | Jeff Cavaliere
29 minEssentials: The Science of Learning & Speaking Languages | Dr. Eddie Chang
151 minHow to Overcome Social Anxiety | Dr. Nick Epley
Ask anything from this episode.
Save it, chat with it, and connect it to Claude or ChatGPT. Get cited answers from the actual content — and build your own knowledge base of every podcast and video you care about.
Get Started Free